Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy von Goldinger, Simone M, Stieger, Pascale, Meier, Barbara, Micaletto, Sara, Contassot, Emmanuel, French, Lars E, Dummer, Reinhard

Volltext

Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report von Murer, Carla, Kränzlin-Stieger, Pascale, French, Lars E, Dummer, Reinhard, Goldinger, Simone M

Volltext

Targeted therapy in melanoma – the role of BRAF, RAS and KIT mutations von Goldinger, Simone M, Murer, Carla, Stieger, Pascale, Dummer, Reinhard

Volltext

Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy von Goldinger, Simone M, Stieger, Pascale, Meier, Barbara, Micaletto, Sara, Contassot, Emmanuel, French, Lars E, Dummer, Reinhard

Volltext

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation von Henning, Benjamin, Stieger, Pascale, Kamarachev, Jivko, Dummer, Reinhard, Goldinger, Simone M

Volltext

Upstream MAPK pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients von Goldinger, Simone M., Murer, Carla, Stieger, Pascale, Dummer, Reinhard

Volltext

Successful treatment with imatinib after nilotinib and ipilimumab in a c-kit-mutated advanced melanoma patient: a case report von Murer, Carla, Kränzlin-Stieger, Pascale, French, Lars E, Dummer, Reinhard, Goldinger, Simone M

Volltext

Pyogenic granuloma in patients treated with selective BRAF inhibitors: another manifestation of paradoxical pathway activation von Henning, Benjamin, Stieger, Pascale, Kamarachev, Jivko, Dummer, Reinhard, Goldinger, Simone M

Volltext

Hautlymphome von Stieger, Pascale, Cozzio, Antonio

Volltext